Real-world study identifies factors predicting immunotherapy response in MSI-H/dMMR gastrointestinal cancers
Skip to content
The CRC Digest
◆ TRIAL DATA
Real-world study identifies factors predicting immunotherapy response in MSI-H/dMMR gastrointestinal cancers — ESMO Real World Data and Digital Oncology
A multicenter retrospective study of 122 patients with advanced MSI-H/dMMR (microsatellite instability-high/mismatch repair deficiency) gastrointestinal tumors treated with immune checkpoint inhibitors